{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:07:46Z","timestamp":1761919666768},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.jvir.2012.10.025","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T23:00:42Z","timestamp":1356044442000},"page":"266-273","source":"Crossref","is-referenced-by-count":25,"title":["Single-center Comparison of Three Chemoembolization Regimens for Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"24","author":[{"given":"Nicholas J.","family":"Petruzzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea J.","family":"Frangos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Fenkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven K.","family":"Herrine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hie-Won","family":"Hann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest L.","family":"Rosato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Eschelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carin F.","family":"Gonsalves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel B.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2012.10.025_bib1","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jvir.2012.10.025_bib2","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"issue":"suppl","key":"10.1016\/j.jvir.2012.10.025_bib3","doi-asserted-by":"crossref","first-page":"S317","DOI":"10.1016\/j.jvir.2009.04.015","article-title":"Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies","volume":"20","author":"Brown","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2012.10.025_bib4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2012.10.025_bib5","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/lt.20884","article-title":"Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time","volume":"12","author":"Decaens","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jvir.2012.10.025_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvir.2012.10.025_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jamcollsurg.2006.06.016","article-title":"Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival","volume":"203","author":"Bharat","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jvir.2012.10.025_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/SLA.0b013e31818a07d4","article-title":"Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation","volume":"248","author":"Chapman","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2012.10.025_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2012.10.025_bib10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.cad.0000127330.21686.26","article-title":"Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials\u2014I : hepatic arterial embolization and embolization-based therapies in unresectable hepatocellular carcinoma","volume":"15","author":"Reidy","year":"2004","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jvir.2012.10.025_bib11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jvir.2011.07.002","article-title":"Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma","volume":"22","author":"Sacco","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2012.10.025_bib12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1051-0443(99)70117-X","article-title":"Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population","volume":"10","author":"Solomon","year":"1999","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2012.10.025_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2214\/AJR.07.2879","article-title":"Chemoembolization of hepatocellular carcinoma: patient status at presentation and outcome over 15 years at a single center","volume":"190","author":"Brown","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2012.10.025_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1148\/radiol.2483071902","article-title":"Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience","volume":"249","author":"Buijs","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2012.10.025_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2012.10.025_bib16","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00270-010-0044-3","article-title":"Safety profile of sequential transcatheter chemoembolization with DC Bead: results of 237 hepatocellular carcinoma (HCC) patients","volume":"34","author":"Malagari","year":"2011","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2012.10.025_bib17","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jhep.2011.03.007","article-title":"EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization","volume":"55","author":"Gillmore","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2012.10.025_bib18","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/j.gastro.2011.04.054","article-title":"Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times","volume":"141","author":"Memon","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2012.10.025_bib19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1148\/radiol.11110282","article-title":"Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models","volume":"262","author":"Shim","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2012.10.025_bib20","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s00270-010-0077-7","article-title":"Chemoembolization decreases drop-off risk of hepatocellular carcinoma patients on the liver transplant list","volume":"34","author":"Frangakis","year":"2011","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2012.10.025_bib21","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jhep.2011.11.020","article-title":"Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis","volume":"56","author":"Memon","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2012.10.025_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jvir.2011.11.029","article-title":"Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy","volume":"23","author":"Brown","year":"2012","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2012.10.025_bib23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jvir.2007.06.028","article-title":"A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion\/MR imaging monitoring","volume":"18","author":"Lewandowski","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2012.10.025_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jvir.2012.10.025_bib25","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and endpoints of clinical trials in hepatocellular carcinoma","volume":"100","author":"Llovet","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jvir.2012.10.025_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.jvir.2012.10.025_bib27","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/01.RVI.0000236608.91960.34","article-title":"Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization","volume":"17","author":"Georgiades","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2012.10.025_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/CAD.0b013e328342231d","article-title":"A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma","volume":"22","author":"Yodono","year":"2011","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jvir.2012.10.025_bib29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/gut.2004.048124","article-title":"Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre","volume":"54","author":"Grieco","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jvir.2012.10.025_bib30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1572-0241.2007.01604.x","article-title":"Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response","volume":"103","author":"Guglielmi","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvir.2012.10.025_bib31","first-page":"183","article-title":"Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma","volume":"50","author":"Barone","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jvir.2012.10.025_bib32","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/01.RVI.0000182160.26798.A2","article-title":"Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents","volume":"16","author":"Brown","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2012.10.025_bib33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/TP.0b013e3182066275","article-title":"Geographic inequity in access to livers for transplantation","volume":"91","author":"Yeh","year":"2011","journal-title":"Transplantation"},{"issue":"suppl","key":"10.1016\/j.jvir.2012.10.025_bib34","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1053\/j.gastro.2004.09.040","article-title":"Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy","volume":"127","author":"Wiesner","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2012.10.025_bib35","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jso.21522","article-title":"Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC)","volume":"101","author":"Dhanasekaran","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jvir.2012.10.025_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/CMAR.S30431","article-title":"Local tumor progression following lipiodol-based targeted chemoembolization of hepatocellular carcinoma: a retrospective comparison of miriplatin and epirubicin","volume":"4","author":"Iwazawa","year":"2012","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.jvir.2012.10.025_bib37","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1051-0443(07)61510-3","article-title":"Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion","volume":"12","author":"Kamada","year":"2001","journal-title":"J Vasc Interv Radiol"},{"issue":"suppl","key":"10.1016\/j.jvir.2012.10.025_bib38","first-page":"S6-38","volume":"24","author":"Kawai","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jvir.2012.10.025_bib39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jvir.2009.10.038","article-title":"Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma","volume":"21","author":"Nicolini","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2012.10.025_bib40","doi-asserted-by":"crossref","unstructured":"Sahara S, Kawai N, Sato M, et al. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol (In press). DOI:10.1007\/s00270-012-0352-x.","DOI":"10.1007\/s00270-012-0352-x"},{"key":"10.1016\/j.jvir.2012.10.025_bib41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MEG.0b013e328346d505","article-title":"Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case-control study of Asian patients","volume":"23","author":"Song","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2012.10.025_bib42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044312011335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044312011335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T03:32:09Z","timestamp":1643945529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044312011335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S1051044312011335"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2012.10.025","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}